We are live on
!
Find out more
Commonwealth Equity Services Portfolio holdings
AUM
$79.5B
1-Year Est. Return
27.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.44%
1 Year Est. Return
+27.1%
3 Year Est. Return
+78.53%
5 Year Est. Return
+87.9%
10 Year Est. Return
+281.22%
AUM
$48.3B
AUM Growth
-$893M
(-1.8%)
Cap. Flow
+$1.08B
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
18.23%
Holding
3,996
New
164
Increased
1,895
Reduced
1,606
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Top 200 Growth ETF
IWY
|
+$98.2M |
| 2 |
Capital Group Growth ETF
CGGR
|
+$90.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$76.9M |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$48.7M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$28.7M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$24.6M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$21.8M |
| 4 |
iShares Core Dividend Growth ETF
DGRO
|
+$19.9M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 60.6% |
| 2 | Technology | 11.15% |
| 3 | Financials | 5.4% |
| 4 | Healthcare | 4.51% |
| 5 | Consumer Discretionary | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
3701
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $30K | ﹤0.01% |
50,296
+4,436
| +10% | +$4.75K |
|
3702
AXT Inc
AXTI
$4.25B
| $29K | ﹤0.01% |
12,156
-311
| -2% | -$822 |
|
3703
C4 Therapeutics
CCCC
$432M
| $29K | ﹤0.01% |
15,471
+61
| +0.4% | +$186 |
|
|
EMX
3704
DELISTED
EMX Royalty
EMX
| $29K | ﹤0.01% |
16,019
-726
| -4% | -$1.33K |
|
3705
X4 Pharmaceuticals
XFOR
$347M
| $29K | ﹤0.01% |
892
+142
| +19% | +$6.19K |
|
3706
Puma Biotechnology
PBYI
$471M
| $28K | ﹤0.01% |
10,749
| – | – |
|
3707
Quantum-Si Incorporated
QSI
$162M
| $28K | ﹤0.01% |
+16,774
| New | +$40.4K |
|
|
AFMD
3708
DELISTED
Affimed
AFMD
| $27K | ﹤0.01% |
5,620
-250
| -4% | -$1.38K |
|
|
FLNT
3709
Fluent
FLNT
$97.7M
| $27K | ﹤0.01% |
10,045
| – | – |
|
3710
Seres Therapeutics
MCRB
$50.3M
| $26K | ﹤0.01% |
+552
| New | +$42.1K |
|
3711
Pyxis Oncology
PYXS
$268M
| $26K | ﹤0.01% |
+12,950
| New | +$30K |
|
|
ADAP
3712
DELISTED
Adaptimmune Therapeutics
ADAP
| $25K | ﹤0.01% |
31,875
| – | – |
|
3713
Atossa Therapeutics
ATOS
$25M
| $25K | ﹤0.01% |
2,223
-84
| -4% | -$1.22K |
|
3714
ESS Tech
GWH
$15.3M
| $25K | ﹤0.01% |
882
-4,231
| -83% | -$103K |
|
3715
Aqua Metals
AQMS
$8.23M
| $24K | ﹤0.01% |
107
| – | – |
|
|
RGLS
3716
DELISTED
Regulus Therapeutics
RGLS
| $24K | ﹤0.01% |
17,500
| – | – |
|
|
TGB
3717
Trekor Metals
TGB
$2.98B
| $24K | ﹤0.01% |
18,695
| – | – |
|
|
VERO
3718
DELISTED
Venus Concept
VERO
| $24K | ﹤0.01% |
1,129
| – | – |
|
3719
Dare Bioscience
DARE
$13.9M
| $23K | ﹤0.01% |
4,111
-21
| -0.5% | -$173 |
|
|
DBVT
3720
DBV Technologies
DBVT
$745M
| $23K | ﹤0.01% |
1,670
| – | – |
|
|
EGIO
3721
DELISTED
Edgio, Inc. Common Stock
EGIO
| $23K | ﹤0.01% |
+661
| New | +$20.7K |
|
|
HELP
3722
Cybin Inc
HELP
$948M
| $22K | ﹤0.01% |
1,087
| – | – |
|
3723
Gevo
GEVO
$388M
| $22K | ﹤0.01% |
18,536
-800
| -4% | -$1.18K |
|
|
OGI
3724
Organigram Holdings
OGI
$151M
| $22K | ﹤0.01% |
16,847
-6,108
| -27% | -$9.21K |
|
|
OTLY
3725
Oatly Group
OTLY
$406M
| $22K | ﹤0.01% |
1,241
-478
| -28% | -$13.9K |
|
Similar funds
BC
Commonwealth Equity Services's Q3 2023 Portfolio in Review
As of Q3 2023, Commonwealth Equity Services held 3,996 positions worth $48.3B, down 1.8% from $49.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Commonwealth Equity Services's Q3 2023 filing shows 164 new, 1,895 increased, 1,606 reduced and 170 closed positions. Its largest new stake was Innovator Equity Defined Protection ETF - 2 Yr to July 2027: 769,999 shares worth $18.8M. The largest sale was iShares S&P Mid-Cap 400 Value ETF, an estimated $28.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 60% a quarter earlier, followed by Technology and Financials.
- Commonwealth Equity Services's largest Q3 2023 buy was Innovator Equity Defined Protection ETF - 2 Yr to July 2027: 769,999 shares worth $18.8M.
- Commonwealth Equity Services added most to iShares Russell Top 200 Growth ETF in Q3 2023, an estimated $98.2M increase.
- Commonwealth Equity Services's biggest Q3 2023 reduction was iShares S&P Mid-Cap 400 Value ETF, cutting an estimated $28.7M.
- Commonwealth Equity Services fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $5.46M.
- Commonwealth Equity Services's ten largest holdings make up 18% of its $48.3B portfolio in Q3 2023.
- Commonwealth Equity Services opened 164 new positions and closed 170 in Q3 2023.
- Commonwealth Equity Services's portfolio value fell 1.8% quarter-over-quarter to $48.3B.
Based on Commonwealth Equity Services's 13F filing for Q3 2023, filed 23 Oct 2023.